{"id":"W3120895755","doi":"10.1200/jco.20.01086","title":"Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration","keywords":"Abatacept; Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Placebo; Calcineurin; Methotrexate; Transplantation; Gastroenterology; Immunology; Clinical trial; Confidence interval; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688344,0.00007759727,0.001174885,0.00007764604,0.00001927989,0.000001583251,0.00005551655,0.0002496451,0.0001548955],"category_scores_gemma":[0.001185341,0.0000564818,0.0004077323,0.0001190096,0.00009051602,0.00006832155,0.000009276258,0.0002543824,6.969493e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003628664,"about_ca_system_score_gemma":0.001349307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001022997,"about_ca_topic_score_gemma":0.000004078608,"domain_scores_codex":[0.9968649,0.0002349919,0.002366184,0.0001146812,0.0003197591,0.00009954859],"domain_scores_gemma":[0.9947429,0.001912344,0.002181747,0.0001285718,0.0009097261,0.0001247189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6430504,0.03406151,0.003101865,0.0006840235,0.0032323,0.0004841197,0.0006845756,0.0001531379,0.03823712,0.0003430698,0.0009275201,0.2750404],"study_design_scores_gemma":[0.6574566,0.2571495,0.008667197,0.0005414536,0.006157397,0.0007318627,0.000178553,0.000620177,0.06260901,0.0005875103,0.005189897,0.0001108688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720711,0.00005744055,0.02436876,0.001557215,0.0006823089,0.0005279177,0.00001730224,0.000003163127,0.0007147689],"genre_scores_gemma":[0.9724795,0.000167303,0.02646847,0.00008961157,0.0004577466,0.00000502011,0.00003192311,0.00001074792,0.0002896879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2749295,"threshold_uncertainty_score":0.2393613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1483854092688785,"score_gpt":0.5169486579838362,"score_spread":0.3685632487149577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}